BIOIMMUNATE TECHNOLOGIES Ltd. develops innovative personalized medical platform to treat autoimmune diseases. We create breakthrough precise medicine technology of blood filtration to autoimmune diseases based on removal of harm cells from the human body. BIOIMMUNATE current R&D is focused on multiple sclerosis (MS) patients.
Company Details
- Employees
- 2
- Address
- Nes Ziona, Il
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.bioimmunate.com/
- HQ
- Nes Ziona
Bioimmunate Technologies Ltd. Questions
Bioimmunate Technologies Ltd.'s website is https://www.bioimmunate.com/
Bioimmunate Technologies Ltd.'s LinkedIn profile is https://il.linkedin.com/company/bioimmunate
Bioimmunate Technologies Ltd. has
2 employees.
View email and phone details for 2
employees at Bioimmunate Technologies Ltd..
Bioimmunate Technologies Ltd.'s industry is
Biotechnology Research
Bioimmunate Technologies Ltd.'s top competitors are
Cell Cure Neurosciences Ltd.,
Evogene,
Compugen,
Futurx,
Ukko,
Point6 Bio,
Mitocarex Bio Ltd,
Alomone Labs,
Seevix Material Sciences,
Nurexone Biologic (Otcqb:nrxbf) (Tsxv: Nrx) (Fse: J90).
Bioimmunate Technologies Ltd.'s categories are Biotechnology Research
